Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma

被引：56

作者：

D'Amato, RJ

Lentzsch, S

Anderson, KC

Rogers, MS

机构：

[1] Childrens Hosp, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期

关键词：

D O I：

10.1053/sonc.2001.28601

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：597 / 601

页数：5

共 47 条

[1] Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases [J].

Arenberg, DA ;

Kunkel, SL ;

Polverini, PJ ;

Morris, SB ;

Burdick, MD ;

Glass, MC ;

Taub, DT ;

Iannettoni, MD ;

Whyte, TI ;

Strieter, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :981-992

[2] Phase II evaluation of thalidomide in patients with metastatic breast cancer [J].

Baidas, SM ;

Winer, EP ;

Fleming, GF ;

Harris, L ;

Pluda, JM ;

Crawford, JG ;

Yamauchi, H ;

Isaacs, C ;

Hanfelt, J ;

Tefft, M ;

Flockhart, D ;

Johnson, MD ;

Hawkins, MJ ;

Lippman, ME ;

Hayes, DF .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2710-2717

[3] Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis [J].

Bekker, LG ;

Haslett, P ;

Maartens, G ;

Steyn, L ;

Kaplan, G .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :954-965

[4] Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1β and tumor necrosis factor α in macrophages:: Implications for their mode of action in rheumatoid arthritis [J].

Bondeson, J ;

Sundler, R .

GENERAL PHARMACOLOGY, 1998, 30 (03) :357-366

[5] THE ROLE OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA IN HUMAN MULTIPLE-MYELOMA [J].

CARTER, A ;

MERCHAV, S ;

SILVIANDRAXLER, I ;

TATARSKY, I .

BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (04) :424-431

[6] Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10 [J].

Cervenak, L ;

Morbidelli, L ;

Donati, D ;

Donnini, S ;

Kambayashi, T ;

Wilson, JL ;

Axelson, H ;

Castaños-Velez, E ;

Ljunggren, HG ;

Malefyt, RD ;

Granger, HJ ;

Ziche, M ;

Bejarano, MT .

BLOOD, 2000, 96 (07) :2568-2573

[7]

Corral LG, 1999, J IMMUNOL, V163, P380

[8] Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity [J].

Corral, LG ;

Muller, GW ;

Moreira, AL ;

Chen, YX ;

Wu, MD ;

Stirling, D ;

Kaplan, G .

MOLECULAR MEDICINE, 1996, 2 (04) :506-515

[9]

Daliani D, 2000, ONCOLOGY-NY, V14, P21

[10] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

← 1 2 3 4 5 →